ICON Clinical Research
ICON Clinical Research
Explore linked clinical trials.8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease | Parkinson disease, autosomal recessive early-onset Parkinson disease 6, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Active, not recruiting | Phase 2 | 2026-10-01 | NCT06015841 | |
| Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations | familial amyloid neuropathy | Recruiting | Not stated | 2026-09-14 | NCT07654855 | |
| A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants and in Participants With Cardiovascular Risk Factors | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Recruiting | Phase 1 | 2026-09-02 | NCT07463196 | |
| Nicotine Pouch Pharmacokinetics Abuse Liability | Smoking Behaviors | Active, not recruiting | Phase 1 | 2026-08-19 | NCT07476144 | |
| A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People With Plaque Psoriasis Over an 8-week Treatment Period | Plaque Psoriasis | Recruiting | Phase 1 | 2026-07-29 | NCT07733089 | |
| Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib Cream | Chronic Hand Eczema (CHE) | Enrolling by invitation | Not stated | 2026-05-22 | NCT07603193 | |
| A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months | hypochondroplasia | Recruiting | Phase 2 | 2026-03-31 | NCT07126262 | |
| Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors | Infections, Skin and Connective Tissue Diseases, nail disorder, paronychia, skin disorder, skin disorder caused by infection | Recruiting | Phase 2 | 2026-03-31 | NCT05639933 |